Published in Eur J Immunol on October 01, 1982
Antibody response of immunodeficient (xid) CBA/N mice to Escherichia coli 0113 lipopolysaccharide, a thymus-independent antigen. J Exp Med (1983) 0.99
Inhibition of lipopolysaccharide mitogenicity with characterized anti-lipid A monoclonal antibodies. Immunology (1985) 0.80
Characterization of the immunodeficiency of RIIIS/J mice: immune response to polysaccharide antigens. Infect Immun (1990) 0.75
Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells. Appl Microbiol (1969) 5.29
Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness. J Exp Med (1972) 5.19
Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J Virol (1989) 4.07
Evidence for the existence of two functionally distinct types of cells which regulate the antibody response to type 3 pneumococcal polysaccharide. J Immunol (1970) 3.94
Defining criteria for autoimmune diseases (Witebsky's postulates revisited) Immunol Today (1993) 3.81
Reaction of endotoxin and surfactants. I. Physical and biological properties of endotoxin treated with sodium deoxycholate. J Bacteriol (1966) 2.86
Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response. Immunology (1971) 2.74
Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum. J Immunol (1970) 2.59
The structure of Pyrococcus furiosus glutamate dehydrogenase reveals a key role for ion-pair networks in maintaining enzyme stability at extreme temperatures. Structure (1995) 2.56
Cellular basis of regulation of expression of idiotype. I. T-suppressor cells specific for MOPC 460 idiotype regulate the expression of cells secreting anti-TNP antibodies bearing 460 idiotype. J Exp Med (1979) 2.53
Preparation and properties of a national reference endotoxin. J Clin Microbiol (1976) 2.30
Hypoferremia in mice and its application to the bioassay of endotoxin. J Bacteriol (1965) 2.25
Physical aspects of reversible inactivation of endotoxin. Ann N Y Acad Sci (1966) 2.21
Chemical composition and biological properties of the endotoxin of Brucella abortus. J Bacteriol (1965) 2.21
Molecular basis of triclosan activity. Nature (1999) 2.18
Mitogenic effect of bacterial peptidoglycans possessing adjuvant activity. J Immunol (1975) 2.15
Regulation of the antibody response to type 3 pneumococcal polysaccharide. I. Nature of regulatory cells. J Exp Med (1973) 2.11
A mechanism of drug action revealed by structural studies of enoyl reductase. Science (1996) 2.03
Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor. Antimicrob Agents Chemother (2001) 2.01
Brevity of the inductive phase in the immune response of mice to capsular polysaccharide antigens. J Immunol (1967) 1.97
Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule. Science (1993) 1.96
Influenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes. J Virol (1992) 1.88
Regulation of the antibody response to type 3 pneumococcal polysaccharide. II. Mode of action of thymic-derived suppressor cells. J Immunol (1974) 1.84
Coexistence of static magnetism and superconductivity in SmFeAsO(1-x)F(x) as revealed by muon spin rotation. Nat Mater (2009) 1.79
Cellular basis of regulation of expression of idiotype. II. Immunity to anti-MOPC-460 idiotype antibodies increases the level of anti-trinitrophenyl antibodies bearing 460 idiotypes. J Exp Med (1979) 1.76
Molecular immunogenicity of bacterial lipopolysaccharide antigens: establishing a quantitative system. J Immunol (1971) 1.75
Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1. J Virol (1993) 1.70
Conformational flexibility in glutamate dehydrogenase. Role of water in substrate recognition and catalysis. J Mol Biol (1993) 1.67
Complement and the direct mediation of immune glomerular injury: a new perspective. Kidney Int (1985) 1.67
Frequency of occurrence of native hapten among enterobacterial species. J Bacteriol (1966) 1.66
Adrenocorticotropic hormone directly stimulates testosterone production by the fetal and neonatal mouse testis. Endocrinology (2003) 1.65
Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. II. Relationship between IgM immunoglobulin levels and the ability to give an IgM antibody response. J Exp Med (1974) 1.64
Magnetic and non-magnetic phases of a quantum spin liquid. Nature (2011) 1.63
Blastic transformtion of mouse spleen lymphocytes by a water-soluble mitogen extracted from Nocardia. Proc Natl Acad Sci U S A (1974) 1.62
Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells. Rev Infect Dis (1981) 1.62
Immune response to levan. I. Kinetics and ontogeny of anti-levan and anti-inulin antibody response and of expression of cross-reactive idiotype. J Immunol (1978) 1.57
Proteases as mitogens. The Effect of trypsin and pronase on mouse and human lymphocytes. Exp Cell Res (1974) 1.56
Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. II. Studies on the relative rate of antibody synthesis and release by antibody-producing cells. Immunology (1971) 1.55
Homeostatic control of antibody responses: a model based on the recognition of cell-associated antibody by regulatory T cells. Transplant Rev (1975) 1.55
Crystal structure of DNA recombination protein RuvA and a model for its binding to the Holliday junction. Science (1996) 1.54
Isolation of mitogenic and adjuvant active fractions from various species of Nocardiae. Infect Immun (1975) 1.54
Spin waves and revised crystal structure of honeycomb iridate Na2IrO3. Phys Rev Lett (2012) 1.49
Glycerol dehydrogenase. structure, specificity, and mechanism of a family III polyol dehydrogenase. Structure (2001) 1.48
Alteration of physical, chemical, and biological properties of endotoxin by treatment with mild alkali. J Bacteriol (1969) 1.48
Identification of a new V kappa gene family that is highly expressed in hybridomas from an autoimmune mouse strain. J Immunol (1990) 1.46
Conditions that induce tolerance in mature CD4+ T cells. J Exp Med (1997) 1.45
Changes in Leydig cell gene expression during development in the mouse. Biol Reprod (2002) 1.42
Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest (1986) 1.42
Kinetics of the antibody response to type III pneumococcal polysaccharide. I. Evidence that suppressor cells function by inhibiting the recruitment and proliferation of antibody-producing cells. J Immunol (1976) 1.42
Mitogenic effect of a water-soluble extract of Nocardia opaca: a comparative study with some bacterial adjuvants on spleen and peripheral lymphocytes of four mammalian species. J Immunol (1974) 1.40
Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells. J Immunol (1971) 1.40
Direct evidence for the involvement of T suppressor cells in the expression of low-dose paralysis to type III pneumococcal polysaccharide. J Immunol (1982) 1.39
Regulation of the antibody response to type 3 pneumococcal polysaccharide. IV. Role of suppressor T cells in the development of low-dose paralysis. J Immunol (1974) 1.38
Analysis of a flawed double-blind, placebo-controlled, clinical trial of patients claimed to have persistent Lyme disease following treatment. Minerva Med (2009) 1.38
Target cells for the activity of a synthetic adjuvant: muramyl dipeptide. Cell Immunol (1977) 1.36
Immune response to levan. III. The capacity to produce anti-inulin antibodies and cross-reactive idiotypes appears late in ontogeny. J Immunol (1979) 1.34
Regulation of the antibody response to type 3 pneumococcal polysaccharide. 3. Role of regulatory T cells in the development of an IgG and IgA antibody response. J Immunol (1974) 1.34
A human T-independent B lymphocyte mitogen extracted from Nocardia opaca. J Immunol (1976) 1.33
Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest (1982) 1.32
Physical structure of a native protoplasmic polysaccharide from Escherichia coli. J Immunol (1967) 1.32
Inactivation of suppressor T-cell activity by nontoxic monophosphoryl lipid A. Infect Immun (1988) 1.31
Hybrid formation between bacterial endotoxins. J Exp Med (1967) 1.26
Targeted disruption of the methionine synthase gene in mice. Mol Cell Biol (2001) 1.26
Blast transformation of rabbit B-derived lymphocytes by a mitogen extracted from Nocardia. J Immunol (1975) 1.25
Detection of terminal complement components in experimental immune glomerular injury. Kidney Int (1984) 1.24
Neonatal treatment with low doses of anti-idiotypic antibody leads to the expression of a silent clone. J Exp Med (1981) 1.24
A biochemical approach to periodontal regeneration: tetracycline treatment of dentin promotes fibroblast adhesion and growth. J Periodontal Res (1986) 1.24
Strain differences in the ability of antithymocyte serum (ATS) to enhance the antibody response of inbred mice to type 3 pneumococcal polysaccharide. Cell Immunol (1973) 1.23
Opsonic IgG antibody against Actinobacillus actinomycetemcomitans in localized juvenile periodontitis. Oral Microbiol Immunol (1989) 1.23
Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol Genet (1996) 1.23
[Serological evolution of infection by Plasmodium malariae: variations of fluorescent antibody titre after radical treatment]. Bull World Health Organ (1969) 1.22
Regulation of the antibody response to type III pneumococcal polysaccharide. V. Ontogeny of factors influencing the magnitude of the plaque-forming cell response. J Immunol (1976) 1.22
Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol (1989) 1.21
Crystallographic analysis of triclosan bound to enoyl reductase. J Mol Biol (1999) 1.20
Comparison of binding characteristics of factors B and H to C3b on normal and paroxysmal nocturnal hemoglobinuria erythrocytes. J Immunol (1983) 1.20
Polyclonal activation of human B lymphocytes by Nocardia water soluble mitogen (NWSM). Immunol Rev (1979) 1.19
Murine V kappa gene expression does not follow the VH paradigm. J Exp Med (1989) 1.19
Alteration and restoration of endotoxin activity after complexing with plasma proteins. J Bacteriol (1966) 1.19
Activation of antigen-specific suppressor T cells by B cells from mice immunized with type III pneumococcal polysaccharide. J Exp Med (1983) 1.19
Cell suppression in PPD-induced blast specific response of human peripheral blood lymphocytes. Clin Exp Immunol (1976) 1.18
Presence and subcellular localization of two distinct mitogenic fractions in the cells of Nocardia rubra and Nocardia opaca: preparation of soluble mitogenic peptidoglycan fractions. Infect Immun (1976) 1.18
The fluorescent antibody technique in the estimation of immunity in patients infected with Plasmodium malariae. Trans R Soc Trop Med Hyg (1966) 1.17
Immunological responses of mice to native protoplasmic polysaccharide and lipopolysaccharide: functional separation of the two signals required to stimulate a secondary antibody response. J Exp Med (1974) 1.17
[The value of the immunofluorescent reaction in the detection of asymptomatic parasitemia due to Plasmodium malariae]. Bull World Health Organ (1967) 1.17
A80915, a new antibiotic complex produced by Streptomyces aculeolatus. Discovery, taxonomy, fermentation, isolation, characterization, and antibacterial evaluation. J Antibiot (Tokyo) (1990) 1.17
Detection and enumeration of antibody-producing cells by specific adherence of antigen-coated bentonite particles. J Immunol (1966) 1.17
The 1.2 A structure of a novel quorum-sensing protein, Bacillus subtilis LuxS. J Mol Biol (2001) 1.17
A biochemical approach to periodontal regeneration: tetracycline treatment conditions dentin surfaces. J Periodontal Res (1986) 1.16
Altered expression of genes involved in regulation of vitamin A metabolism, solute transportation, and cytoskeletal function in the androgen-insensitive tfm mouse testis. Endocrinology (2007) 1.14
Regulation of the anti-inulin antibody response by a nonallotype-linked gene. J Exp Med (1980) 1.14
Common themes in redox chemistry emerge from the X-ray structure of oilseed rape (Brassica napus) enoyl acyl carrier protein reductase. Structure (1995) 1.14
Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes. J Invest Dermatol (2001) 1.13
Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycations. J Immunol (1975) 1.13
Mitogenic analysis of murine B-cell heterogeneity. J Exp Med (1978) 1.13
Cell surface antigens and other characteristics of T cells regulating the antibody response to type III pneumococcal polysaccharide. J Immunol (1983) 1.12
Modification of selected host-reactive properties of endotoxin by treatment with sodium deoxycholate. J Bacteriol (1968) 1.12
Tannerella forsythia-induced alveolar bone loss in mice involves leucine-rich-repeat BspA protein. J Dent Res (2005) 1.12